BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28214639)

  • 1. Congenital Glioblastoma with Distinct Clinical and Molecular Characteristics: Case Reports and a Literature Review.
    Kameda M; Otani Y; Ichikawa T; Shimada A; Ichimura K; Date I
    World Neurosurg; 2017 May; 101():817.e5-817.e14. PubMed ID: 28214639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital glioblastoma multiforme. Case report and review of the literature.
    Seker A; Ozek MM
    J Neurosurg; 2006 Dec; 105(6 Suppl):473-9. PubMed ID: 17184081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case Report of Spontaneous Resolution of a Congenital Glioblastoma.
    Davis T; Doyle H; Tobias V; Ellison DW; Ziegler DS
    Pediatrics; 2016 Apr; 137(4):. PubMed ID: 26980879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome 1p and 19q deletions in glioblastoma multiforme.
    Kaneshiro D; Kobayashi T; Chao ST; Suh J; Prayson RA
    Appl Immunohistochem Mol Morphol; 2009 Dec; 17(6):512-6. PubMed ID: 19602970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiological features of infantile glioblastoma and desmoplastic infantile tumors: British Columbia's Children's Hospital experience.
    Bader A; Heran M; Dunham C; Steinbok P
    J Neurosurg Pediatr; 2015 Aug; 16(2):119-25. PubMed ID: 25955808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of p53 mutations in proliferating vascular cells in glioblastoma multiforme.
    Kawasoe T; Takeshima H; Yamashita S; Mizuguchi S; Fukushima T; Yokogami K; Yamasaki K
    J Neurosurg; 2015 Feb; 122(2):317-23. PubMed ID: 25415071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentrations of glial fibrillary acidic protein (GFAP) do not indicate tumor recurrence in patients with glioblastoma.
    Vietheer JM; Rieger J; Wagner M; Senft C; Tichy J; Foerch C
    J Neurooncol; 2017 Oct; 135(1):193-199. PubMed ID: 28717884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups.
    Hinrichs BH; Newman S; Appin CL; Dunn W; Cooper L; Pauly R; Kowalski J; Rossi MR; Brat DJ
    Acta Neuropathol Commun; 2016 Jan; 4():4. PubMed ID: 26757882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of glioblastoma multiforme with long term survival: can we predict the outcome?
    Kumar A; Deopujari C; Karmarkar V
    Turk Neurosurg; 2012; 22(3):378-81. PubMed ID: 22665013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glioblastoma multiforme in patients with history of extracranial cancer: Case series.
    Kalita O; Trojanec R; Megova M; Hajduch M; Vaverka M; Hrabalek L; Zlevorova M; Drabek J; Tuckova L; Vrbkova J
    Clin Neurol Neurosurg; 2016 May; 144():39-43. PubMed ID: 26971293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of MGMT promoter status in non-resectable glioblastoma after adjuvant therapy.
    Iaccarino C; Orlandi E; Ruggeri F; Nicoli D; Torricelli F; Maggi M; Cerasti D; Pisanello A; Pedrazzi G; Froio E; Crafa P; D'Abbiero N; Michiara M; Ghadirpour R; Servadei F
    Clin Neurol Neurosurg; 2015 May; 132():1-8. PubMed ID: 25723791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.
    Galanis E; Buckner JC; Dinapoli RP; Scheithauer BW; Jenkins RB; Wang CH; O'Fallon JR; Farr G
    J Neurosurg; 1998 Sep; 89(3):425-30. PubMed ID: 9724117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of oligodendroglioma specific chromosomal copy number changes in the glioblastoma MI-4 cell line by array-CGH and FISH analyses.
    Magnani I; Moroni RF; Roversi G; Beghini A; Pfundt R; Schoenmakers EF; Larizza L
    Cancer Genet Cytogenet; 2005 Sep; 161(2):140-5. PubMed ID: 16102584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers.
    Korshunov A; Ryzhova M; Hovestadt V; Bender S; Sturm D; Capper D; Meyer J; Schrimpf D; Kool M; Northcott PA; Zheludkova O; Milde T; Witt O; Kulozik AE; Reifenberger G; Jabado N; Perry A; Lichter P; von Deimling A; Pfister SM; Jones DT
    Acta Neuropathol; 2015 May; 129(5):669-78. PubMed ID: 25752754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
    Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
    Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case Report: Next generation sequencing identifies a NAB2-STAT6 fusion in Glioblastoma.
    Diamandis P; Ferrer-Luna R; Huang RY; Folkerth RD; Ligon AH; Wen PY; Beroukhim R; Ligon KL; Ramkissoon SH
    Diagn Pathol; 2016 Jan; 11():13. PubMed ID: 26817999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of O6-methylguanine-DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation: a prospective patient cohort.
    Metellus P; Coulibaly B; Nanni I; Fina F; Eudes N; Giorgi R; Barrie M; Chinot O; Fuentes S; Dufour H; Ouafik L; Figarella-Branger D
    Cancer; 2009 Oct; 115(20):4783-94. PubMed ID: 19637364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
    Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
    BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
    Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
    J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.